AbbVie Reports Third-Quarter 2022 Financial Results

Reports Third-Quarter Diluted EPS of $2.21 on a GAAP Basis, an Increase of 24.2 Percent; Adjusted Diluted EPS of $3.66, an Increase of 29.3 Percent; These Results Include an Unfavorable Impact of $0.02 Per Share related to Acquired IPR&D and Milestones Expense 1 Delivers Third-Quarter Net…

About the Author

has written 41532 stories on this site.

Copyright © 2010 Business and Corporate News.